PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Neurology, Hospital Universitario 12 de Octubre, Avda. de Córdoba, s/n 28041, Madrid, Spain. victorantonio.blanco@salud.madrid.org.\', \'Group of Neurodegenerative Diseases, Instituto de Investigación Hospital 12 de Octubre (i+12), Madrid, Spain. victorantonio.blanco@salud.madrid.org.\', \'Networked Biomedical Research Center in Neurodegenerative Diseases (CIBERNED), Madrid, Spain. victorantonio.blanco@salud.madrid.org.\', \'Department of Neurology, Hospital Universitario 12 de Octubre, Avda. de Córdoba, s/n 28041, Madrid, Spain.\', \'Department of Clinical Analysis, Hospital Universitario 12 de Octubre, Madrid, Spain.\', \'Department of Microbiology, Hospital Universitario 12 de Octubre, Madrid, Spain.\', \'Department of Internal Medicine, Hospital Universitario 12 de Octubre, Madrid, Spain.\', \'Group of Neurodegenerative Diseases, Instituto de Investigación Hospital 12 de Octubre (i+12), Madrid, Spain.\', \'Networked Biomedical Research Center in Neurodegenerative Diseases (CIBERNED), Madrid, Spain.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1007/s00415-021-10444-6
?:doi
?:hasPublicationType
?:journal
  • Journal of neurology
is ?:pmid of
?:pmid
?:pmid
  • 33606070
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.626
?:rankingScore_hIndex
  • 118
is ?:relation_isRelatedTo_publication of
?:title
  • Serum and CSF alpha-synuclein levels do not change in COVID-19 patients with neurological symptoms.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all